Retraction statement: 'Long-term efficacy and safety of blonanserin in patients with first-episode schizophrenia: A 1-year open-label trial' by Y. Ninomiya, S. Miyamoto, T. Tenjin, S. Ogino, N. Miyake, Y. Kaneda, T. Sumiyoshi and N. Yamaguchi.

Publikováno v: Psychiatry and clinical neurosciences [Psychiatry Clin Neurosci] 2017 Jul; Vol. 71 (7), pp. 506.

Retraction statement: 'Long-term efficacy and safety of blonanserin in patients with first-episode schizophrenia: A 1-year open-label trial' by Y. Ninomiya, S. Miyamoto, T. Tenjin, S. Ogino, N. Miyake, Y. Kaneda, T. Sumiyoshi and N. Yamaguchi

Publikováno v: Psychiatry and clinical neurosciences. 71(7)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::bbcd7528f2e12b9e50f3ad773232c7c8
https://pubmed.ncbi.nlm.nih.gov/24835911

Twist along Central C-C Bonds in a Series of Fully π-Fused Propellanes.

Autor: Kato K; Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University Katsura, Nishikyo-ku, Kyoto, 615-8510, Japan., Tanaka K; Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University Katsura, Nishikyo-ku, Kyoto, 615-8510, Japan., Okada S; Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University Katsura, Nishikyo-ku, Kyoto, 615-8510, Japan., Kaneda T; Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University Katsura, Nishikyo-ku, Kyoto, 615-8510, Japan., Ohtani S; Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University Katsura, Nishikyo-ku, Kyoto, 615-8510, Japan., Ogoshi T; Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University Katsura, Nishikyo-ku, Kyoto, 615-8510, Japan.; WPI Nano Life Science Institute, Kanazawa University Kakuma-machi, Kanazawa, 920-1192, Japan.

Publikováno v: Chemistry (Weinheim an der Bergstrasse, Germany) [Chemistry] 2024 Aug 21, pp. e202402828. Date of Electronic Publication: 2024 Aug 21.

Vincazalidine A, a unique bisindole alkaloid from Catharanthus roseus.

Autor: Hirasawa Y; Faculty of Pharmaceutical Sciences, Hoshi University, Ebara 2-4-41 Shinagawa-Ku, Tokyo, 142-8501, Japan. y-hirasawa@hoshi.ac.jp., Kase A; Faculty of Pharmaceutical Sciences, Hoshi University, Ebara 2-4-41 Shinagawa-Ku, Tokyo, 142-8501, Japan., Okamoto A; Faculty of Pharmaceutical Sciences, Hoshi University, Ebara 2-4-41 Shinagawa-Ku, Tokyo, 142-8501, Japan., Suzuki K; Faculty of Pharmaceutical Sciences, Hoshi University, Ebara 2-4-41 Shinagawa-Ku, Tokyo, 142-8501, Japan., Hiroki M; Faculty of Pharmaceutical Sciences, Hoshi University, Ebara 2-4-41 Shinagawa-Ku, Tokyo, 142-8501, Japan., Kaneda T; Faculty of Pharmaceutical Sciences, Hoshi University, Ebara 2-4-41 Shinagawa-Ku, Tokyo, 142-8501, Japan., Uchiyama N; National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-Ku, Kawasaki, Kanagawa, 210-9501, Japan., Morita H; Faculty of Pharmaceutical Sciences, Hoshi University, Ebara 2-4-41 Shinagawa-Ku, Tokyo, 142-8501, Japan. moritah@hoshi.ac.jp.

Publikováno v: Journal of natural medicines [J Nat Med] 2024 Mar; Vol. 78 (2), pp. 382-392. Date of Electronic Publication: 2024 Feb 12.

Ceramicines U-Z from Chisocheton ceramicus and structure-antimalarial activity relationship study.

Autor: Nugroho AE; Faculty of Pharmaceutical Sciences, Hoshi University, Ebara 2-4-41 Shinagawa-Ku, Tokyo, 142-8501, Japan., Komuro T; Faculty of Pharmaceutical Sciences, Hoshi University, Ebara 2-4-41 Shinagawa-Ku, Tokyo, 142-8501, Japan., Kawaguchi T; Faculty of Pharmaceutical Sciences, Hoshi University, Ebara 2-4-41 Shinagawa-Ku, Tokyo, 142-8501, Japan., Shindo Y; Faculty of Pharmaceutical Sciences, Hoshi University, Ebara 2-4-41 Shinagawa-Ku, Tokyo, 142-8501, Japan., Wong CP; Faculty of Pharmaceutical Sciences, Hoshi University, Ebara 2-4-41 Shinagawa-Ku, Tokyo, 142-8501, Japan., Hirasawa Y; Faculty of Pharmaceutical Sciences, Hoshi University, Ebara 2-4-41 Shinagawa-Ku, Tokyo, 142-8501, Japan. y-hirasawa@hoshi.ac.jp., Kaneda T; Faculty of Pharmaceutical Sciences, Hoshi University, Ebara 2-4-41 Shinagawa-Ku, Tokyo, 142-8501, Japan., Tougan T; Research Center for Infectious Disease Control, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka, 565-0871, Japan., Horii T; Department of Malaria Vaccine Development, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka, 565-0871, Japan., Hadi AHA; Department of Chemistry, Faculty of Science, University of Malaya, 50603, Kuala Lumpur, Malaysia., Morita H; Faculty of Pharmaceutical Sciences, Hoshi University, Ebara 2-4-41 Shinagawa-Ku, Tokyo, 142-8501, Japan. moritah@hoshi.ac.jp.

Publikováno v: Journal of natural medicines [J Nat Med] 2024 Jan; Vol. 78 (1), pp. 68-77. Date of Electronic Publication: 2023 Sep 10.